Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; State Petitions for Exemption From Preemption, 34024-34025 [E8-13522]
Download as PDF
34024
Federal Register / Vol. 73, No. 116 / Monday, June 16, 2008 / Notices
Dated: June 9, 2008.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E8–13493 Filed 6–13–08; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
Medicaid Program; Notice of SingleSource Grant Award to the States of
Louisiana and Mississippi for the
Grant Entitled ‘‘Deficit Reduction ActHurricane Katrina Healthcare Related
Provider Stabilization’’
Centers for Medicare &
Medicaid Services (CMS).
ACTION: Notice of Single-Source NonCompetitive Supplemental Awards.
AGENCY:
rwilkins on PROD1PC63 with NOTICES
Funding Amount: $19,100,000.
Period of Performance: June 9, 2008–
September 30, 2009.
CFDA: 93.776.
Authority: Section 6201(a)(4) of the
Deficit Reduction Act of 2005 (DRA)
Purpose: The Secretary has authorized
an additional $19.1 million in
supplemental grant funds to be made
available to the States of Louisiana and
Mississippi. Based on the share of total
Medicare inpatient payments made to
each State’s eligible general acute care
hospitals and inpatient psychiatric
facilities (IPFs) located in the Federal
Emergency Management Agency
(FEMA) designated counties/parishes in
calendar year 2006 (the latest and most
complete year of Medicare billing data
available to us), funding is being
allocated in the following proportions:
53 percent to Louisiana ($10,143,671)
and 47 percent to Mississippi
($8,956,329).
Since its inception, the Provider
Stabilization Grant (PSG) program has
been used to fund State payments to
general acute care hospitals, skilled
nursing facilities, IPFs, and community
mental health centers in impacted
communities that may face financial
pressures because of changing wage
rates that are not yet reflected in
Medicare prospective payment system
(PPS) payment methodologies. For this
third round of PSG funding, CMS
determined that these supplemental
grant funds would be used by the States
to make payments to only those
Medicare participating inpatient PPS
(IPPS) hospitals and IPFs that are
currently paid under a Medicare PPS
VerDate Aug<31>2005
17:04 Jun 13, 2008
Jkt 214001
and that are the most significantly,
negatively impacted (financial or
otherwise) related to Hurricane Katrina.
Although the States had significant
discretion in determining the payment
distribution methodology, the
methodology had to clearly reflect the
basis upon which the State would
determine ‘‘negative impact’’ and then
how each provider would receive an
appropriate share of the funds. Grant
funds may not be distributed to IPPS
hospitals and IPFs that are not in
operation or that are outside of the
FEMA Hurricane Katrina designated
counties/parishes for individual and
public assistance. The States’ payment
methodologies were to specify the
relevant time periods and any other
factors that would be considered in
distributing available grant funds
according to the principles specified
above, and were subject to approval by
CMS.
The States were also allowed to
choose to use a portion of the funds (not
to exceed 20% of the grant) to address
immediate, unmet, health care
infrastructure needs that objective data
indicate was caused as a direct result of
Hurricane Katrina and or its subsequent
flooding. This optional provision was
also subject to CMS approval.
Under the authority of section
6201(a)(4) of the Deficit Reduction Act
of 2005, the Secretary, Department of
Health and Human Services, has
invoked his authority to restore health
care in impacted communities affected
by Hurricane Katrina by offering this
unique funding opportunity to enable
States to make payments to assist
general acute care hospitals and IPFs
that are paid under a Medicare PPS,
with the financial pressures that may
result from changing wage rates in those
impacted communities. Louisiana and
Mississippi are the only States with
knowledge and ability to administer a
grant designed to affect impacted
communities in their own respective
States. For the reasons cited above, the
Secretary has directed CMS to offer
supplemental single-source awards to
the States of Louisiana and Mississippi.
FOR FURTHER INFORMATION CONTACT:
Wendy J. Alexander, Ph.D., Health
Insurance Specialist, Finance Systems
and Budget Group, Centers for Medicaid
and State Operations, Centers for
Medicare & Medicaid Services, Mail
Stop S3–13–15, 7500 Security
Boulevard, Baltimore, MD 21244, (410)
786–5245.
Authority: Section 6201(a)(4) of the Deficit
Reduction Act of 2005 (DRA).
PO 00000
Frm 00054
Fmt 4703
Sfmt 4703
Dated: June 10, 2008.
Kerry Weems,
Acting Administrator, Centers for Medicare
& Medicaid Services.
[FR Doc. E8–13525 Filed 6–13–08; 8:45 am]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2008–N–0132]
Agency Information Collection
Activities; Submission for Office of
Management and Budget Review;
Comment Request; State Petitions for
Exemption From Preemption
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
SUMMARY: The Food and Drug
Administration (FDA) is announcing
that a proposed collection of
information has been submitted to the
Office of Management and Budget
(OMB) for review and clearance under
the Paperwork Reduction Act of 1995.
DATES: Fax written comments on the
collection of information by July 16,
2008.
ADDRESSES: To ensure that comments on
the information collection are received,
OMB recommends that written
comments be faxed to the Office of
Information and Regulatory Affairs,
OMB, Attn: FDA Desk Officer, FAX:
202–395–6974, or e-mailed to
baguilar@omb.eop.gov. All comments
should be identified with the OMB
control number 0910–0277. Also
include the FDA docket number found
in brackets in the heading of this
document.
FOR FURTHER INFORMATION CONTACT:
Jonna Capezzuto, Office of the Chief
Information Officer (HFA–250), Food
and Drug Administration, 5600 Fishers
Lane, Rockville, MD 20857, 301–827–
4659.
SUPPLEMENTARY INFORMATION: In
compliance with 44 U.S.C. 3507, FDA
has submitted the following proposed
collection of information to OMB for
review and clearance.
State Petitions for Exemption From
Preemption—21 CFR 100.1(d) (OMB
Control No. 0910–0277)—Extension
Under section 403A(b) of the Federal
Food, Drug, and Cosmetic Act (the act)
(21 U.S.C. 343–1(b)), States may petition
FDA for exemption from Federal
preemption of State food labeling and
standard of identity requirements.
E:\FR\FM\16JNN1.SGM
16JNN1
34025
Federal Register / Vol. 73, No. 116 / Monday, June 16, 2008 / Notices
Section 100.1(d) (21 CFR 100.1(d)) sets
forth the information a State is required
to submit in such a petition. The
information required under § 100.1(d)
enables FDA to determine whether the
State food labeling or standard of
identity requirement satisfies the
criteria of section 403A(b) of the act for
granting exemption from Federal
preemption.
In the Federal Register of March 4,
2008 (73 FR 11648), FDA published a
60-day notice requesting public
comment on the information collection
provisions. No comments were received.
TABLE 1.—ESTIMATED ANNUAL REPORTING BURDEN1
No. of
Respondents
21 CFR Section
100.1(d)
1 There
1
Total Annual
Responses
1
Hours per
Response
1
Total Hours
40
40
are no capital costs or operating and maintenance costs associated with this collection of information.
The reporting burden for § 100.1(d) is
minimal because petitions for
exemption from preemption are seldom
submitted by States. In the last 3 years,
FDA has not received any new petitions
for exemption from preemption;
therefore, the agency estimates that one
or fewer petitions will be submitted
annually. Although FDA has not
received any new petitions for
exemption from preemption in the last
3 years, it believes these information
collection provisions should be
extended to provide for the potential
future need of a State or local
government to petition for an exemption
from preemption under the provisions
of section 403(A) of the act.
Dated: June 10, 2008.
Jeffrey Shuren,
Associate Commissioner for Policy and
Planning.
[FR Doc. E8–13522 Filed 6–13–08; 8:45 am]
BILLING CODE 4160–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Recruitment of Sites for Assignment of
Corps Personnel
Health Resources and Services
Administration (HRSA), HHS.
ACTION: General notice.
AGENCY:
rwilkins on PROD1PC63 with NOTICES
Annual Frequency
per Response
SUMMARY: The Health Resources and
Services Administration (HRSA)
announces that the listing of entities,
and their Health Professional Shortage
Area (HPSA) scores, that will receive
priority for the assignment of National
Health Service Corps (NHSC) personnel
(Corps Personnel, Corps members) for
the period July 1, 2008, through June 30,
2009, is posted on the NHSC Web site
at https://nhsc.bhpr.hrsa.gov/jobs/
index.asp. This list specifies which
entities are eligible to receive
assignment of Corps members who are
participating in the NHSC Scholarship
VerDate Aug<31>2005
17:04 Jun 13, 2008
Jkt 214001
Program, the NHSC Loan Repayment
Program, and Corps members who have
become Corps members other than
pursuant to contractual obligations
under the Scholarship or Loan
Repayment Programs. Please note that
not all vacancies associated with sites
on this list will be for Corps members,
but could be for individuals serving an
obligation to the NHSC through the
Private Practice Option.
Eligible HPSAs and Entities
To be eligible to receive assignment of
Corps personnel, entities must: (1) Have
a current HPSA designation by the
Office of Shortage Designation, Bureau
of Health Professions, Health Resources
and Services Administration; (2) not
deny requested health care services, or
discriminate in the provision of services
to an individual because the individual
is unable to pay for the services or
because payment for the services would
be made under Medicare, Medicaid, or
the State Children’s Health Insurance
Program; (3) enter into an agreement
with the State agency that administers
Medicaid, accept payment under
Medicare and the State Children’s
Health Insurance Program, see all
patients regardless of their ability to
pay, and use and post a discounted fee
plan; and (4) be determined by the
Secretary to have (a) A need and
demand for health manpower in the
area; (b) appropriately and efficiently
used Corps members assigned to the
entity in the past; (c) general community
support for the assignment of Corps
members; (d) made unsuccessful efforts
to recruit; and (e) a reasonable prospect
for sound fiscal management by the
entity with respect to Corps members
assigned there. Priority in approving
applications for assignment of Corps
members goes to sites that (1) Provide
primary medical care, mental health,
and/or oral health services to a primary
medical care, mental health, or dental
HPSA of greatest shortage, respectively;
(2) are part of a system of care that
provides a continuum of services,
including comprehensive primary
PO 00000
Frm 00055
Fmt 4703
Sfmt 4703
health care and appropriate referrals or
arrangements for secondary and tertiary
care; (3) have a documented record of
sound fiscal management; and (4) will
experience a negative impact on its
capacity to provide primary health
services if a Corps members is not
assigned to the entity.
Entities that receive assignment of
Corps personnel must assure that (1) the
position will permit the full scope of
practice and that the clinician meets the
credentialing requirements of the State
and site; and (2) the Corps member
assigned to the entity is engaged in fulltime clinical practice at the approved
service location for a minimum of 40
hours per week with at least 32 hours
per week in the ambulatory care setting.
Obstetricians/gynecologists, certified
nurse midwives (CNMs), and family
practitioners who practice obstetrics on
a regular basis, are required to engage in
a minimum of 21 hours per week of
outpatient clinical practice. The
remaining hours, making up the
minimum 40-hour per week total,
include delivery and other clinical
hospital-based duties. For all Corps
personnel, time spent on-call does not
count toward the 40 hours per week. In
addition, sites receiving assignment of
Corps personnel are expected to (1)
Report to the NHSC all absences,
including those in excess of the
authorized number of days (up to 35
work days or 280 hours per contract
year); (2) report to the NHSC any change
in the status of an NHSC clinician at the
site; (3) provide the time and leave
records, schedules, and any related
personnel documents for NHSC
assignees (including documentation, if
applicable, of the reason(s) for the
termination of an NHSC clinician’s
employment at the site prior to his or
her obligated service end date); and (4)
submit a Uniform Data System (UDS)
report. The UDS allows the site to assess
the age, sex, race/ethnicity of, and
provider encounter records for, its user
population. The UDS reports are site
specific. Providers fulfilling NHSC
commitments are assigned to a specific
E:\FR\FM\16JNN1.SGM
16JNN1
Agencies
[Federal Register Volume 73, Number 116 (Monday, June 16, 2008)]
[Notices]
[Pages 34024-34025]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-13522]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2008-N-0132]
Agency Information Collection Activities; Submission for Office
of Management and Budget Review; Comment Request; State Petitions for
Exemption From Preemption
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is announcing that a
proposed collection of information has been submitted to the Office of
Management and Budget (OMB) for review and clearance under the
Paperwork Reduction Act of 1995.
DATES: Fax written comments on the collection of information by July
16, 2008.
ADDRESSES: To ensure that comments on the information collection are
received, OMB recommends that written comments be faxed to the Office
of Information and Regulatory Affairs, OMB, Attn: FDA Desk Officer,
FAX: 202-395-6974, or e-mailed to baguilar@omb.eop.gov. All comments
should be identified with the OMB control number 0910-0277. Also
include the FDA docket number found in brackets in the heading of this
document.
FOR FURTHER INFORMATION CONTACT: Jonna Capezzuto, Office of the Chief
Information Officer (HFA-250), Food and Drug Administration, 5600
Fishers Lane, Rockville, MD 20857, 301-827-4659.
SUPPLEMENTARY INFORMATION: In compliance with 44 U.S.C. 3507, FDA has
submitted the following proposed collection of information to OMB for
review and clearance.
State Petitions for Exemption From Preemption--21 CFR 100.1(d) (OMB
Control No. 0910-0277)--Extension
Under section 403A(b) of the Federal Food, Drug, and Cosmetic Act
(the act) (21 U.S.C. 343-1(b)), States may petition FDA for exemption
from Federal preemption of State food labeling and standard of identity
requirements.
[[Page 34025]]
Section 100.1(d) (21 CFR 100.1(d)) sets forth the information a State
is required to submit in such a petition. The information required
under Sec. 100.1(d) enables FDA to determine whether the State food
labeling or standard of identity requirement satisfies the criteria of
section 403A(b) of the act for granting exemption from Federal
preemption.
In the Federal Register of March 4, 2008 (73 FR 11648), FDA
published a 60-day notice requesting public comment on the information
collection provisions. No comments were received.
Table 1.--Estimated Annual Reporting Burden\1\
----------------------------------------------------------------------------------------------------------------
No. of Annual Frequency Total Annual Hours per
21 CFR Section Respondents per Response Responses Response Total Hours
----------------------------------------------------------------------------------------------------------------
100.1(d) 1 1 1 40 40
----------------------------------------------------------------------------------------------------------------
\1\ There are no capital costs or operating and maintenance costs associated with this collection of
information.
The reporting burden for Sec. 100.1(d) is minimal because
petitions for exemption from preemption are seldom submitted by States.
In the last 3 years, FDA has not received any new petitions for
exemption from preemption; therefore, the agency estimates that one or
fewer petitions will be submitted annually. Although FDA has not
received any new petitions for exemption from preemption in the last 3
years, it believes these information collection provisions should be
extended to provide for the potential future need of a State or local
government to petition for an exemption from preemption under the
provisions of section 403(A) of the act.
Dated: June 10, 2008.
Jeffrey Shuren,
Associate Commissioner for Policy and Planning.
[FR Doc. E8-13522 Filed 6-13-08; 8:45 am]
BILLING CODE 4160-01-S